SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SE_01_002400597 | chr9:112830946-112869790![]() |
Sample_01_0024 | Blood | CD14-positive-monocyte | 597 | 5 | 1111 | 142 | 32 | 49 | 522 | SNX30,SLC46A2 |
SE_02_133000519 | chr9:112831462-112873128![]() |
Sample_02_1330 | Blood | AMU-AML1 | 519 | 17 | 1170 | 150 | 38 | 52 | 933 | SNX30,SLC46A2 |
SE_02_072900488 | chr9:112837943-112873053![]() |
Sample_02_0729 | Lymphoma | I10_Mantle cell lymphoma tissue_THZ1 | 488 | 13 | 989 | 127 | 37 | 45 | 865 | SNX30,SLC46A2 |
SE_02_072800595 | chr9:112837981-112873001![]() |
Sample_02_0728 | Lymphoma | I10_Mantle cell lymphoma tissue_DMSO | 595 | 12 | 988 | 127 | 37 | 45 | 858 | SNX30,SLC46A2 |
SE_02_157301062 | chr9:112839633-112903772![]() |
Sample_02_1573 | Endothelial | Undifferentiated Pleomorphic Sarcoma | 1062 | 20 | 1791 | 223 | 48 | 96 | 1611 | SNX30,SLC46A2 |
SE_02_104602867 | chr9:112843483-112888211![]() |
Sample_02_1046 | Peripheral blood | CD4+ cells_CTCL1145 | 2867 | 18 | 1239 | 134 | 44 | 69 | 1255 | SNX30,SLC46A2 |
SE_02_010200660 | chr9:112844612-112872143![]() |
Sample_02_0102 | Peripheral blood | Macrophages_GM-CSF_72h_IL4 | 660 | 7 | 768 | 96 | 35 | 36 | 663 | SNX30,SLC46A2 |
SE_02_025500494 | chr9:112844743-112868026![]() |
Sample_02_0255 | Haematopoietic and lymphoid tissue | MOLM13 | 494 | 5 | 679 | 83 | 29 | 15 | 235 | SNX30,SLC46A2 |
SE_02_025600414 | chr9:112844809-112869692![]() |
Sample_02_0256 | Peripheral blood | MV411 | 414 | 4 | 713 | 87 | 30 | 32 | 367 | SNX30,SLC46A2 |
SE_02_099400662 | chr9:112844944-112867729![]() |
Sample_02_0994 | Blood | MOLM13_SIK3TQ | 662 | 11 | 663 | 80 | 29 | 13 | 235 | SNX30,SLC46A2 |
SE_02_138600749 | chr9:112844963-112864504![]() |
Sample_02_1386 | Peripheral blood | Karpas-299_ALK+ | 749 | 12 | 566 | 72 | 28 | 13 | 215 | SNX30,SLC46A2 |
SE_02_099300547 | chr9:112844972-112868113![]() |
Sample_02_0993 | Blood | MOLM-13_empty | 547 | 12 | 672 | 82 | 29 | 15 | 235 | SNX30,SLC46A2 |
SE_02_099500730 | chr9:112844980-112866089![]() |
Sample_02_0995 | Blood | MOLM-13_empty vector | 730 | 10 | 626 | 80 | 29 | 13 | 235 | SNX30,SLC46A2 |
SE_02_046500837 | chr9:112844988-112868563![]() |
Sample_02_0465 | Adipose | subcutaneous adipocytes | 837 | 7 | 680 | 83 | 29 | 15 | 235 | SNX30,SLC46A2 |
SE_02_010300571 | chr9:112845006-112865220![]() |
Sample_02_0103 | Peripheral blood | Macrophages_GM-CSF_72h_TNF-a_PGE2_Pam3CSK4 | 571 | 3 | 597 | 76 | 29 | 13 | 235 | SNX30,SLC46A2 |
SE_02_061100503 | chr9:112845030-112869568![]() |
Sample_02_0611 | Liposarcoma | DDLPS_T1 | 503 | 10 | 705 | 86 | 30 | 31 | 362 | SNX30,SLC46A2 |
SE_00_000600209 | chr9:112848128-112873067![]() |
Sample_00_0006 | Blood | CD14-positive-monocyte | 209 | 3 | 701 | 89 | 34 | 36 | 796 | SNX30,SLC46A2 |
SE_02_109800825 | chr9:112848274-112866947![]() |
Sample_02_1098 | Blood | THP1_DMSO_noPMA | 825 | 6 | 556 | 71 | 25 | 11 | 235 | SNX30,SLC46A2 |
SE_02_134500636 | chr9:112855849-112868268![]() |
Sample_02_1345 | Leukophereses | leukophereses_p358 | 636 | 7 | 357 | 28 | 5 | 11 | 84 | SNX30,SLC46A2 |
SE_02_034200767 | chr9:112856363-112872968![]() |
Sample_02_0342 | Liver | HSPCs_F0 | 767 | 3 | 446 | 41 | 12 | 34 | 635 | SNX30,SLC46A2 |
SE_02_062200555 | chr9:112857130-112869610![]() |
Sample_02_0622 | Blood | EOL1_Naive | 555 | 8 | 354 | 30 | 6 | 27 | 212 | SNX30,SLC46A2 |
SE_02_134100346 | chr9:112857795-112869239![]() |
Sample_02_1341 | Blood | MV411 | 346 | 1 | 326 | 23 | 3 | 22 | 164 | SNX30,SLC46A2 |
SE_02_046100361 | chr9:112858087-112867788![]() |
Sample_02_0461 | Blood | MV-4-11-B cells | 361 | 4 | 277 | 16 | 3 | 9 | 84 | SNX30,SLC46A2 |
SE_02_046300400 | chr9:112858321-112865461![]() |
Sample_02_0463 | Blood | OCI-AML3 cells | 400 | 10 | 212 | 13 | 3 | 9 | 84 | SNX30,SLC46A2 |